Abu Dhabi healthcare company Burjeel Holdings is aiming to do more clinical trials in the UAE, as it seeks to boost its ...

When Columbia neurologist and scientist Neil Shneider speaks to his ALS patients who volunteer for experimental therapies, he's unwaveringly honest. "Patients always ask me, 'What can I hope to get ...

The notion that we should require placebo trials even when there's already a safe, effective vaccine goes against decades of ...

ILC accounts for 10–15% of breast cancers and often goes undetected. Learn about its characteristics, treatments, and future ...

Luspatercept showed real-world efficacy among patients with lower-risk myelodysplastic syndrome (MDS), confirming results ...

The short follow-up period and elderly population may impact the trial’s prognostic significance and generalizability.

The FDA plans to limit access to certain high-risk groups and also told Pfizer and Moderna to update their warning labels about heart inflammation.

On Clinical Trials Day, speakers emphasized how lack of representation impacts medical care for Black women and strategies for participation.

The FDA is likely to approve the first treatment for smoldering multiple myeloma but pass on a new option relapsed/refractory DLBCL, after votes by its Oncologic Drugs Advisory Committee.

In patients with active or chronic thyroid eye disease, veligrotug improved symptoms of proptosis and diplopia and clinical ...

Secukinumab use leads to sustained alleviation of pain as well as improvements in quality of life in patients with moderate ...

Matthew Starr, MD, highlights the RHONE-X trial's findings on faricimab, showcasing improved vision and reduced treatment ...